Development Level

Tclin 3 | 602
Tbio 2 | 10,625

IMPC Term

abnormal vocalization 1 | 21
decreased leukocyte cell numbe... 1 | 54
decreased lumbar vertebrae num... 1 | 62
increased sacral vertebrae num... 1 | 62
preweaning lethality, incomple... 1 | 260

Disease

Cancer 5 | 2,346
Carcinoma 4 | 2,147
atypical teratoid / rhabdoid tumor 4 | 4,369
ovarian cancer 4 | 8,484
ulcerative colitis 4 | 2,087
Breast cancer 3 | 3,094
Disease Progression 3 | 125
Mammary Neoplasms 3 | 410
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung cancer 3 | 4,466
lung carcinoma 3 | 2,844
pancreatic cancer 3 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
spina bifida 3 | 1,064
Adenocarcinoma 2 | 115
Adenocarcinoma of lung (disorder) 2 | 48
Adenoma 2 | 165
Animal Mammary Neoplasms 2 | 136
Cholangiocarcinoma 2 | 32
Colonic Neoplasms 2 | 126
Diarrhea 2 | 155
Esophageal Neoplasms 2 | 67
Exanthem 2 | 39
Glioma 2 | 65
HER2 Positive Carcinoma of Breast 2 | 2
Kidney cancer 2 | 118
Lung Neoplasms 2 | 171
Mammary Neoplasms, Experimental 2 | 150
Neoplasm Metastasis 2 | 138
Neoplasm Recurrence, Local 2 | 23
Neutropenia 2 | 78
Non-small cell lung cancer, positive for epidermal growth factor receptor expression 2 | 4
Papilloma 2 | 27
Pick disease 2 | 1,893
Prostatic Neoplasms 2 | 471
Rheumatoid Arthritis 2 | 1,160
Stomach Neoplasms 2 | 282
Stomatitis 2 | 19
adrenocortical carcinoma 2 | 1,427
breast carcinoma 2 | 1,614
cutaneous lupus erythematosus 2 | 1,056
ductal carcinoma in situ 2 | 1,745
gallbladder neoplasm 2 | 9
glioblastoma 2 | 5,572
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
invasive ductal carcinoma 2 | 2,950
medulloblastoma 2 | 1,524
medulloblastoma, large-cell 2 | 6,234
nasopharyngeal carcinoma 2 | 1,056
non-small cell lung carcinoma 2 | 413
osteosarcoma 2 | 7,933
ovarian neoplasm 2 | 97
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
sarcoidosis 2 | 358
Acute kidney injury 1 | 65
Alopecia 1 | 55
Anemia 1 | 252
Arthritis, Experimental 1 | 39
Barrett's esophagus 1 | 183
Bladder Neoplasm 1 | 109
Carcinoma of thyroid 1 | 17
Cataract 1 | 104
Chloracne 1 | 32
Colorectal Neoplasms 1 | 217
Comedo carcinoma 1 | 2
Craniofacial Abnormalities 1 | 147
DOID:2627 1 | 14
Developmental Disabilities 1 | 20
Gastrointestinal Neoplasms 1 | 4
Giant Cell Glioblastoma 1 | 12
Growth Disorders 1 | 33
HER2-positive carcinoma of breast 1 | 10
Head and Neck Neoplasms 1 | 23
Hematologic cancer 1 | 9
Homocystinuria 1 | 23
Immune system cancer 1 | 38
Juvenile Myelomonocytic Leukemia 1 | 21
Liver carcinoma 1 | 217
Lobular neoplasia 1 | 15
Malignant glioma 1 | 23
Mesothelioma 1 | 40
Methylmalonic acidemia 1 | 39
Nasopharyngeal Neoplasms 1 | 8
Neoplasm Invasiveness 1 | 127
Neuropathy 1 | 210
Paronychia 1 | 7
Pernicious anemia 1 | 10
Pleomorphic adenoma 1 | 18
Pulmonary Embolism 1 | 45
Renal Cell Carcinoma 1 | 199
Squamous cell carcinoma 1 | 94
Squamous cell carcinoma of esophagus 1 | 82
Squamous cell carcinoma of the head and neck 1 | 24
Thrombocytopenia 1 | 105
Uterine Cervical Neoplasm 1 | 21
Vitamin B12 deficiency 1 | 20
gliosarcoma 1 | 19

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Kinase 4 | 634
Enzyme 1 | 4,146

Grant Application

5R01CA114071-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.22922 19000.3 3336
Epidermal growth factor receptor EGFR Tclin Kinase -3.95948 9318.1 4989
E3 ubiquitin-protein ligase CBL CBL Tbio Enzyme -2.89085 850.0 753
Ephrin-A1 EFNA1 Tbio Kinase -1.97284 94.5 212
Ephrin type-A receptor 2 EPHA2 Tclin Kinase -2.84710 785.1 704